The Novel Cellular Mechanism of Human 5-HT6 Receptor through an Interaction with Fyn*

The human 5-HT6 receptor (5-HT6R) is one of the latest cloned receptors among the known 5-HT receptors. Its abundant distribution in the limbic region, which participates in the control of mood and emotion and is involved in nervous system diseases such as depression and Alzheimer disease, has caused it to generate much interest. However, the cellular mechanisms of 5-HT6R are poorly understood. In the present study we found, using a yeast two-hybrid assay, that the carboxyl-terminal region of 5-HT6R interacts with the Fyn-tyrosine kinase. We also determined using a glutathione S-transferase pulldown assay that this interaction was mediated through the SH3 domain of Fyn and confirmed this by co-immunoprecipitation assays in two different transfected cell lines as well as in adult rat brains. Immunocyto(histo)chemistry also showed prominent co-localization between 5-HT6R and Fyn in transfected cells and a similar distribution between 5-HT6R and Fyn in the rat brain. Based on this interaction, we further examined the modulation of 5-HT6R by Fyn and vice versa. In addition, we demonstrated that the activation of 5-HT6R activated the extracellular signal-regulated kinase1/2 via an Fyn-dependent pathway. These findings suggest that Fyn may play an important role in 5-HT6R- mediated signaling pathways in the central nervous system.

• Publication year

  2007

• Venue

  Journal of Biological Chemistry

• Publication date

  2007-02-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.M606215200PMID 17189269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients

  2006cited by this paper
• Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease

  2005cited by this paper
• Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau*

  2005cited by this paper
• Developmental Abnormalities of Myelin Basic Protein Expression in fyn Knock-out Brain Reveal a Role of Fyn in Posttranscriptional Regulation*

  2005cited by this paper
• 5-HT6 receptors: a novel target for cognitive enhancement.

  2005cited by this paper
• The tryptophan switch: changing ligand-binding specificity from type I to type II in SH3 domains.

  2004cited by this paper
• 5-ht6 receptors.

  2004cited by this paper
• Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease

  2004cited by this paper
• Src kinases: a hub for NMDA receptor regulation

  2004cited by this paper
• Ras-dependent ERK Activation by the Human Gs-coupled Serotonin Receptors 5-HT4(b) and 5-HT7(a) *

  2003cited by this paper
• MAP Kinase Stimulation by cAMP Does Not Require RAP1 but SRC Family Kinases*

  2002cited by this paper
• Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation.

  2002cited by this paper
• Novel regulation and function of Src tyrosine kinase

  2002cited by this paper
• 5-HT6 receptor antagonists enhance retention of a water maze task in the rat

  2001cited by this paper
• Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain.

  2001cited by this paper
• Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice.

  2001cited by this paper
• A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.

  2001cited by this paper
• Is Gα16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors?

  2001cited by this paper
• Aβ amyloidosis induces the initial stage of tau accumulation in APPSw mice

  2001cited by this paper
• Is Galpha16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors?

  2001cited by this paper
• Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease.

  1999cited by this paper
• Morphological Differentiation of Oligodendrocytes Requires Activation of Fyn Tyrosine Kinase

  1999cited by this paper
• Characterization of 5-ht6 receptor and expression of 5-ht6 mRNA in the rat brain during ontogenetic development

  1998cited by this paper
• Repeated pulses of serotonin required for long-term facilitation activate mitogen-activated protein kinase in sensory neurons of Aplysia.

  1998cited by this paper
• Fyn, a Src family tyrosine kinase.

  1998cited by this paper
• Central distribution and function of 5-HT6 receptor subtype in the rat brain.

  1998cited by this paper
• Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function.

  1997cited by this paper
• cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway.

  1997cited by this paper
• Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus.

  1997cited by this paper
• Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells.

  1997cited by this paper
• MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia.

  1997cited by this paper
• Role of 5-HT in stress, anxiety, and depression.

  1996cited by this paper
• Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

  1996cited by this paper
• Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor

  1996cited by this paper
• Serotonergic control of the organization of feeding and satiety.

  1995cited by this paper
• Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry.

  1995cited by this paper
• Increased fearfulness of Fyn tyrosine kinase deficient mice.

  1994cited by this paper
• Initial events of myelination involve Fyn tyrosine kinase signalling

  1994cited by this paper
• Vascular receptors for 5-hydroxytryptamine: distribution, function and classification.

  1994cited by this paper
• Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

  1994cited by this paper
• International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

  1994cited by this paper
• Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.

  1993cited by this paper
• Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases.

  1993cited by this paper
• p59fyn in rat brain is localized in developing axonal tracts and subpopulations of adult neurons and glia.

  1993cited by this paper
• A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation.

  1993cited by this paper
• Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.

  1993cited by this paper
• Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice.

  1992cited by this paper
• Specific expressions of Fyn and Lyn, lymphocyte antigen receptor-associated tyrosine kinases, in the central nervous system.

  1992cited by this paper
• yes-related protooncogene, syn, belongs to the protein-tyrosine kinase family.

  1986cited by this paper

• 5-HT6 receptors: Contemporary views on their neurobiological and pharmacological relevance in neuropsychiatric disorders

  2025cites this paper
• ST1936 stimulates osteoclastogenesis and suppresses osteoclastic apoptosis through the ERK1/2 signaling pathway in bone marrow-derived macrophages.

  2025cites this paper
• Serotonergic Regulation in Alzheimer’s Disease

  2025cites this paper
• 5-HT6 receptor neutral antagonists protect astrocytes: A lesson from 2-phenylpyrrole derivatives.

  2024cites this paper
• Serotonin Signaling through Lipid Membranes

  2024cites this paper
• Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src

  2024cites this paper
• Activation of 5-HT6 Receptors in the Ventrolateral Orbital Cortex Produces Anti-Anxiodepressive Effects in a Rat Model of Neuropathic Pain

  2024cites this paper
• Systemic Modulators: Potential Mechanism for the 5-HT System to Mediate Exercise Amelioration in Alzheimer's Disease

  2024cites this paper
• Impact of 5-HT6 Receptor Subcellular Localization on Its Signaling and Its Pathophysiological Roles

  2023cites this paper
• Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease

  2023cites this paper
• Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial.

  2023cites this paper
• Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders

  2023cites this paper
• The brain serotonin system in autism

  2023cites this paper
• Suffruticosol B Is an Osteogenic Inducer through Osteoblast Differentiation, Autophagy, Adhesion, and Migration

  2022cites this paper
• CRHR1-mediated Akt activation involves endocytosis and soluble adenylyl cyclase activity

  2022cites this paper
• Chi3L1 is a therapeutic target in bone metabolism and a potential clinical marker in patients with osteoporosis.

  2022cites this paper
• Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders

  2022cites this paper
• Latifolin, a Natural Flavonoid, Isolated from the Heartwood of Dalbergia odorifera Induces Bioactivities through Apoptosis, Autophagy, and Necroptosis in Human Oral Squamous Cell Carcinoma

  2022cites this paper
• Roles of non-receptor tyrosine kinases in pathogenesis and treatment of depression

  2022cites this paper
• Hypothalamic TRH Mediates Anorectic Effects of Serotonin in Rats

  2022cites this paper
• Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment

  2022influential citation
• Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota–Gut–Brain Axis

  2021cites this paper
• Kiss1/Gpr54 Prevents Bone Loss through Src Dephosphorylation by Dusp18 in Osteoclasts

  2021cites this paper
• Rewiring of the Serotonin System in Major Depression

  2021cites this paper
• Fyn kinase inhibition using AZD0530 improves recognition memory and reduces depressive-like behaviour in an experimental model of Parkinson’s disease

  2021cites this paper
• Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties

  2021cites this paper
• Is the Exposome Involved in Brain Disorders through the Serotoninergic System?

  2021cites this paper
• Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia

  2020cites this paper
• Gene expression of serotonergic markers in peripheral blood mononuclear cells of patients with late-onset Alzheimer's disease

  2020cites this paper
• The 5-HT6 Receptors in the Ventrolateral Orbital Cortex Attenuate Allodynia in a Rodent Model of Neuropathic Pain

  2020cites this paper
• Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.

  2020cites this paper
• Phosphorylation barcode-dependent signal bias of the dopamine D1 receptor

  2020cites this paper
• Classification and signaling characteristics of 5-HT receptors: toward the concept of 5-HT receptosomes

  2020cites this paper
• Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis

  2020cites this paper
• Dynamic interactions of the 5-HT6 receptor with protein partners control dendritic tree morphogenesis

  2020cites this paper
• Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia

  2020cites this paper
• The 5-HT6 receptor interactome: new insight in receptor signaling and its impact on brain physiology and pathologies.

  2020cites this paper
• Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology

  2020cites this paper
• Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia

  2020cites this paper
• Physical and Functional Interaction between 5-HT6 Receptor and Nova-1

  2019cites this paper
• 5-HT6 receptor agonist and antagonist improve memory impairments and hippocampal BDNF signaling alterations induced by MK-801.

  2019cites this paper
• Dual 5-HT6 and D3 Receptor Antagonists in a Group of 1 H-Pyrrolo[3,2- c]quinolines with Neuroprotective and Procognitive Activity.

  2019cites this paper
• Multi-functionality of proteins involved in GPCR and G protein signaling: making sense of structure–function continuum with intrinsic disorder-based proteoforms

  2019cites this paper
• Constitutive SRC-mediated phosphorylation of pannexin 1 at tyrosine 198 occurs at the plasma membrane

  2019cites this paper
• Serotonin type 6 receptor antagonist attenuates the impairment of long‐term potentiation and memory induced by Abeta

  2019cites this paper
• The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment

  2019cites this paper
• Ligand-induced activation of ERK1/2 signaling by constitutively active Gs-coupled 5-HT receptors

  2019cites this paper
• Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT6 Receptor Antagonist SB-399885

  2018cites this paper
• Novel non-sulfonamide 5-HT6 receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties.

  2018cites this paper
• Pyrroloquinoline scaffold-based 5-HT6R ligands: Synthesis, quantum chemical and molecular dynamic studies, and influence of nitrogen atom position in the scaffold on affinity.

  2018cites this paper
• Le récepteur 5-HT6 et la dynamique de son réceptosome : rôle dans la différenciation neuronale et potentiel thérapeutique pour le traitement des troubles de spectre de l'autisme

  2018cites this paper
• 5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer’s disease

  2018cites this paper
• Restoration of Physiological Expression of 5-HT6 Receptor into the Primary Cilia of Null Mutant Neurons Lengthens Both Primary Cilia and Dendrites

  2018cites this paper
• Monoamines in glioblastoma: complex biology with therapeutic potential

  2018cites this paper
• Restoration of physiological expression of 5-HT 6 into the primary cilia of null mutant neurons lengthens both primary cilia and dendrites.

  2018influential citation
• Chronic antidepressant-like effect of EMD386088, a partial 5-HT_6 receptor agonist, in olfactory bulbectomy model may be connected with BDNF and/or CREB signalling pathway

  2018cites this paper
• 4-parvifuran inhibits metastatic and invasive actions through the JAK2/STAT3 pathway in osteosarcoma cells

  2017cites this paper
• Alzheimer’s Disease II

  2017cites this paper
• Inhibitors of Tau-Phosphorylating Kinases

  2017cites this paper
• 5-HT6 receptor blockade regulates primary cilia morphology in striatal neurons.

  2017cites this paper
• The Role of 5-HTR6 in Mossy Fiber Sprouting: Activating Fyn and p-ERK1/2 in Pilocarpine-Induced Chronic Epileptic Rats

  2017cites this paper
• Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.

  2017cites this paper
• 5-Hydroxytryptamine 6 Receptor (5-HT6R)-Mediated Morphological Changes via RhoA-Dependent Pathways

  2017cites this paper
• Antagonism of the 5-HT6 receptor - Preclinical rationale for the treatment of Alzheimer's disease.

  2017cites this paper
• RANKL-induced osteoclastogenesis is suppressed by 4-O-methylhonokiol in bone marrow-derived macrophages

  2017cites this paper
• Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity

  2016cites this paper
• Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia.

  2016cites this paper
• Sulfuretin promotes osteoblastic differentiation in primary cultured osteoblasts and in vivo bone healing

  2016cites this paper
• Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.

  2016cites this paper
• The role of serotonin receptors in Alzheimer’s disease

  2016cites this paper
• Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer’s Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?

  2016cites this paper
• Antistress Effects of Rosa rugosa Thunb. on Total Sleep Deprivation–Induced Anxiety-Like Behavior and Cognitive Dysfunction in Rat: Possible Mechanism of Action of 5-HT6 Receptor Antagonist

  2016cites this paper
• Peripheral serotonin-mediated system suppresses bone development and regeneration via serotonin 6 G-protein-coupled receptor

  2016cites this paper
• Combined Effects of Growth Hormone and Mineral Trioxide Aggregate on Growth, Differentiation, and Angiogenesis in Human Dental Pulp Cells.

  2016cites this paper
• 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway

  2016cites this paper
• Serotonin 5-HT6 Receptor Antagonists in Alzheimer’s Disease: Therapeutic Rationale and Current Development Status

  2016cites this paper
• Striatal 5-HT6 receptors: Roles in cocaine reinforcement and neuronal primary cilia

  2016cites this paper
• 5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia.

  2015cites this paper
• 5-HT6 receptor agonism facilitates emotional learning

  2015cites this paper
• Therapeutic Potential of 5-HT6 Receptor Agonists.

  2015cites this paper
• 5-HT6 Receptor: A New Player Controlling the Development of Neural Circuits.

  2015cites this paper
• Serotonin and cancer: what is the link?

  2015cites this paper
• SNX14 is a bifunctional negative regulator for neuronal 5‐HT6 receptor signaling

  2015cites this paper
• Serotonin 6 receptor controls alzheimer’s disease and depression

  2015cites this paper
• Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer’s disease

  2015cites this paper
• PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model.

  2015cites this paper
• Neurotransmitters and Memory

  2014cites this paper
• Direct Interaction and Functional Coupling between Human 5-HT6 Receptor and the Light Chain 1 Subunit of the Microtubule-Associated Protein 1B (MAP1B-LC1)

  2014cites this paper
• Effect of Acute and Chronic Electroconvulsive Shock on 5-Hydroxytrypamine 6 Receptor Immunoreactivity in Rat Hippocampus

  2014cites this paper
• The genetics and epigenetics of substance misuse : an investigation into life stress and reward processing in adolescence

  2014cites this paper
• The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia

  2014cites this paper
• Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative

  2014cites this paper
• Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.

  2014cites this paper
• Modulation of N-methyl-D-aspartate receptors by Gαs- and Gαi/o-coupled receptors

  2013cites this paper
• The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats

  2013cites this paper
• Leading compounds for the validation of animal models of psychopathology

  2013cites this paper
• Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology.

  2013cites this paper
• 5-HT6 receptors and Alzheimer's disease

  2013cites this paper
• Evidence for a role of a dopamine/5-HT6 receptor interaction in cocaine reinforcement.

  2013cites this paper
• 5‐HT2C and 5‐HT6 Receptor Targeted Emerging Approaches in Schizophrenia

  2012cites this paper